Schroder Investment Management Group Has $23.91 Million Stock Position in Chemed Co. (NYSE:CHE)

Schroder Investment Management Group boosted its holdings in shares of Chemed Co. (NYSE:CHE) by 1.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 45,291 shares of the company’s stock after buying an additional 463 shares during the quarter. Schroder Investment Management Group’s holdings in Chemed were worth $23,906,000 at the end of the most recent reporting period.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Chemed in the fourth quarter valued at $95,872,000. Raymond James Financial Inc. acquired a new position in Chemed in the 4th quarter valued at about $42,023,000. FMR LLC raised its holdings in Chemed by 23.8% in the 3rd quarter. FMR LLC now owns 238,616 shares of the company’s stock valued at $143,401,000 after acquiring an additional 45,917 shares during the period. Principal Financial Group Inc. lifted its position in Chemed by 114.1% during the fourth quarter. Principal Financial Group Inc. now owns 74,658 shares of the company’s stock worth $39,554,000 after acquiring an additional 39,791 shares during the last quarter. Finally, Segall Bryant & Hamill LLC bought a new stake in shares of Chemed during the fourth quarter worth approximately $12,880,000. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insider Activity

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of the business’s stock in a transaction that occurred on Monday, March 31st. The shares were sold at an average price of $615.33, for a total value of $615,330.00. Following the completion of the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at approximately $62,566,139.07. The trade was a 0.97 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 3.32% of the company’s stock.

Wall Street Analysts Forecast Growth

CHE has been the topic of a number of recent research reports. Royal Bank of Canada increased their target price on Chemed from $633.00 to $667.00 and gave the stock an “outperform” rating in a research note on Friday, March 14th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.

Chemed Stock Down 0.7 %

Shares of NYSE:CHE opened at $614.41 on Thursday. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $639.61. The company’s 50 day moving average price is $577.76 and its two-hundred day moving average price is $567.62. The firm has a market cap of $8.99 billion, a PE ratio of 31.05, a PEG ratio of 2.15 and a beta of 0.43.

Chemed Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, February 24th. This represents a $2.00 dividend on an annualized basis and a yield of 0.33%. Chemed’s dividend payout ratio (DPR) is presently 10.05%.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.